Jiangsu Hengrui reported CNY71.29B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Cspc Pharmaceutical CNY 46.7B 695.56M Dec/2025
Kangmei Pharma CNY 13.31B 375.64M Mar/2026
Sh Fosun Pharma CNY 122.97B 2.91B Mar/2026
Sh Pharmaceutical CNY 233.15B 3.6B Dec/2025
Sino Biopharmaceutical CNY 74.89B 9.49B Jun/2025
Wuxi Apptec CNY 107.41B 4.29B Mar/2026
Zz Pientze Pharmaceu CNY 18.38B 905.93M Mar/2026